![David Jin, Hematologist-Oncologist](/doctor_images/c/c5/8131577.jpg)
David Jin
Hematologist-Oncologist | Hematology & Oncology
6 Clinton Court Staten Island New York, 10301About
David Jin, MD, PhD, is a well-versed clinical-scientist in hematology, oncology and regenerative medicine with over a decade of experience in his field. He maintains a private medical office, serves as Chief Medical Officer at BioTime, Inc., and Chief Medical Officer at OncoCyte Corporation. Dr. Jin also acts as a Senior Translational Scientist at the Howard Hughes Medical Institute and the Ansary Stem Cell Center at Cornell. Prior to his current endeavors, Dr. Jin worked for the Food and Drug Administration in the United States as Medical Reviewer at the Oncology Product Development Division. He also was Chief Consultant/Advisor for various biotech/pharmaceutical companies regarding hematology, oncology, immunotherapy and stem cell-based technology development. Dr. Jin has been Principle Investigator in more than 15 pre-clinical and clinical trials, as well as author/co-author of over 80 peer-reviewed scientific abstracts, articles, reviews, and book chapters. He received his clinical training and subsequent faculty tenure at the New York-Presbyterian Hospital (the teaching hospital for both Cornell and Columbia Universities) in the areas of internal medicine, hematology, and clinical oncology. He received was honored as Top Chief Medical Officer in 2012.
Education and Training
SUNY Downstate
MD
PhD
Provider Details
Areas of expertise and specialization
Faculty Titles & Positions
- Speaking on Research and Development of Stem Cell Cancer Therapy and Traditional Medicine -
- Senior Clinician Scientist, Ansary Stem Cell Institute and Howard Hughes Medical Institute -
- Cofounder of the Center of Excellence in Translational Medicine, Corey Institute of Biomedical Research -
Awards
- Top Chief Medical Officer, 2012
Fellowships
- New York Presbysterian Hospital (Hematology and Oncology)
Articles and Publications
- 30 Peer Reviewed Articles (including Nature, Nature Medicine, Cell, PNAS, JCI)
Areas of research
- Translation research in stem cell biology, cancer and vascular medicine. Principle investigator in more than 15 pre-clinical and clinical trials
Areas of research
Translation research in stem cell biology, cancer and vascular medicine. Principle investigator in more than 15 pre-clinical and clinical trialsDavid Jin's Practice location
David Jin's reviews
Write ReviewRecommended Articles
- The Promising Future of Gene Therapy and Lymphoma
Non-Hodgkin lymphoma affects over 700,000 people in America alone. Though current treatments are moderately effective, especially for aggressive forms of the disease, more can be done to help people impacted by NHL. Researchers are doing just that by working to develop new, innovative treatment for...
- 'Sophie the Brave' Fights Childhood T-Cell Lymphoma
The story of 2-year-old Sophie Skiles and her arduous battle with T-cell lymphoma pulls at one’s heartstrings while also causing one to marvel at the faith of her Mom, Shelby.The public first learned of Sophie when a newscast about her was posted online October 20, 2017. (KLTB/abc) It soon made it...
- Teen with Hodgkin Lymphoma Skates with Her Hero, Mario Lemieux
Lillian Tarasiewicz was diagnosed with stage 3B Hodgkin lymphoma in October of 2015. She currently resides in South Carolina, but because of her father’s Pennsylvania background, she grew up with a love for hockey and for the Pittsburgh Penguins. She always felt a special connection to Mario...
- Lymphoma: The Importance of a Support System & Communication
Regardless of what’s being said, communication is something that many people struggle with in their personal relationships. Communication requires self-awareness, listening skills, and the ability to empathize and convey thoughts and feelings accurately. When people are diagnosed with chronic...
- Arizona Firefighters Raise Funds for Lymphoma Stairclimb
Jackson County Fire District #5 partnered with Dutch Bros. Coffee in Phoenix, Arizona to help raise funds for the Leukemia & Lymphoma Society’s Scott Firefighter Stairclimb in Seattle, which took place at the Columbia Center on March 11th, 2018. All of the money raised for the stairclimb go to...
- Treatment Update for Hodgkin Lymphoma
Over time, research has uncovered ways of treating Hodgkin lymphoma (HL) to produce an 80% to 90% cure rate. For the remaining 10% to 20% who are either resistant to the primary treatment or have relapsed, their cancer can still be fatal.The standard care for those not yet cured has been a two-step...
Nearest Hospitals
CAREPOINT HEALTH - BAYONNE MEDICAL CENTERl
29 EAST 29TH ST BAYONNE NJ 7002STATEN ISLAND UNIVERSITY HOSPITALl
475 SEAVIEW AVENUE STATEN ISLAND NY 10305